HB STRATEGIES

Lobbying for BAYER U.S. LLC · Pharmaceutical and life sciences company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $120,000.00 income · posted Jan 19, 2026

Lobbying activity 3

Health Issues

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Agriculture

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Pharmacy

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.